Blood-Based Biomarker Testing for Alzheimer Disease in US Clinical Practice

This cohort study examines the rates of blood-based biomarker testing for Alzheimer disease in US clinical practice, exploring patient characteristics, ordering clinician specialty, and diagnostic and treatment events.

Authors

Institutions

Publication Details

Journal
JAMA
Published
2026-11-18
DOI
https://doi.org/10.1001/jama.2026.23534
Primary Topic
Dementia and Cognitive Impairment Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Blood-Based Biomarker Testing for Alzheimer Disease in US Clinical Practice

Reshma Ramachandran, Joseph S. Ross, Karina M. Berg, Matthew Andersen et al.
5 links
JAMA
Dementia and Cognitive Impairment Research
article

Blood-Based Biomarker Testing for Alzheimer Disease in US Clinical Practice

Reshma Ramachandran, Joseph S. Ross, Karina M. Berg, Matthew Andersen, Mengyuan Fu
article en

Abstract

This cohort study examines the rates of blood-based biomarker testing for Alzheimer disease in US clinical practice, exploring patient characteristics, ordering clinician specialty, and diagnostic and treatment events.

JAMA
University of Connecticut (US), Peking University (CN), Yale University (US), Yale New Haven Health System (US), UConn Health (US)
Good health and well-being
Dementia and Cognitive Impairment Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon